Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'DROMER F' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 32 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Boekhout, T; Theelen, B; Diaz, M; Fell, JW; Hop, WCJ; Abeln, ECA; Dromer, F; Meyer, W
      Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans

      MICROBIOLOGY-UK
    2. Janbon, G; Himmelreich, U; Moyrand, F; Improvisi, L; Dromer, F
      Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide

      MOLECULAR MICROBIOLOGY
    3. Garcia-Hermoso, D; Dromer, F; Mathoulin-Pelissier, S; Janbon, G
      Are two Cryptococcus neoformans strains epidemiologically linked?

      JOURNAL OF CLINICAL MICROBIOLOGY
    4. Lortholary, O; Dromer, F; Mathoulin-Pelissier, S; Fitting, C; Improvisi, L; Cavaillon, JM; Dupont, B
      Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus

      JOURNAL OF INFECTIOUS DISEASES
    5. Nail, S; Robert, R; Dromer, F; Marot-Leblond, A; Senet, JM
      Susceptibilities of Cryptococcus neoformans strains to platelet binding invivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro

      INFECTION AND IMMUNITY
    6. Kwon-Chung, KJ; Sorrell, TC; Dromer, F; Fung, E; Levitz, SM
      Cryptococcosis: clinical and biological aspects

      MEDICAL MYCOLOGY
    7. Neuville, S; Lortholary, O; Dromer, F
      Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome?

      INFECTION AND IMMUNITY
    8. Rayhane, N; Fitting, C; Lortholary, O; Dromer, F; Cavaillon, JM
      Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection

      INFECTION AND IMMUNITY
    9. Lortholary, O; Improvisi, L; Nicolas, M; Provost, F; Dupont, B; Dromer, F
      Fungemia during murine cryptococcosis sheds some light on pathophysiology

      MEDICAL MYCOLOGY
    10. Lortholary, O; Nicolas, M; Soreda, S; Improvisi, L; Ronin, O; Petitjean, O; Dupont, B; Tod, M; Dromer, F
      Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing

      Journal of antimicrobial chemotherapy
    11. Garcia-Hermoso, D; Janbon, G; Dromer, F
      Epidemiological evidence for dormant Cryptococcus neoformans infection

      JOURNAL OF CLINICAL MICROBIOLOGY
    12. Rayhane, N; Lortholary, O; Fitting, C; Callebert, J; Huerre, M; Dromer, F; Cavaillon, JM
      Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12

      JOURNAL OF INFECTIOUS DISEASES
    13. Lortholary, O; Improvisi, L; Rayhane, N; Gray, F; Fitting, C; Cavaillon, JM; Dromer, F
      Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection

      INFECTION AND IMMUNITY
    14. VANDENBOSSCHE H; DROMER F; IMPROVISI I; LOZANOCHIU M; REX JH; SANGLARD D
      ANTIFUNGAL DRUG-RESISTANCE IN PATHOGENIC FUNGI

      MEDICAL MYCOLOGY
    15. DROMER F; IMPROVISI L; DUPONT B; ELIASZEWICZ M; PIALOUX G; FOURNIER S; FEUILLIE V
      ORAL-TRANSMISSION OF CANDIDA-ALBICANS BETWEEN PARTNERS IN HIV-INFECTED COUPLES COULD CONTRIBUTE TO DISSEMINATION OF FLUCONAZOLE-RESISTANT ISOLATES

      AIDS
    16. GARCIAHERMOSO D; MATHOULINPELISSIER S; COUPRIE B; RONIN O; DUPONT B; DROMER F
      DNA TYPING SUGGESTS PIGEON DROPPINGS AS A SOURCE OF PATHOGENIC CRYPTOCOCCUS-NEOFORMANS SEROTYPE-D

      Journal of clinical microbiology
    17. DROMER F; RONIN O; IMPROVISI L; DUPONT B
      VALUE AND LIMITS OF BICHRO-LATEX ALBICANS (R) FOR THE RAPID IDENTIFICATION OF CANDIDA-ALBICANS

      Journal de mycologie medicale
    18. DUPONT BF; DROMER F; IMPROVISI L
      THE PROBLEM OF AZOLE RESISTANCE IN CANDIDA

      Journal de mycologie medicale
    19. STEVENS DA; ZINGMAN BS; DUPONT BF; POLSKY B; EPSTEIN JB; GUIOT HFL; DROMER F
      THE PROBLEM OF AZOLE RESISTANCE IN CANDIDA - DISCUSSION

      Journal de mycologie medicale
    20. STEVENS DA; DUPONT BF; MONTES LF; POLSKY B; DROMER F; GUIOT HFL; ZINGMAN BS
      USE OF ORAL AMPHOTERICIN-B IN HUMANS FOR SITES OTHER THAN THE MOUTH AND GI TRACT - DISCUSSION

      Journal de mycologie medicale
    21. DROMER F; DUPONT B
      THE INCREASING PROBLEM OF FUNGAL-INFECTIONS IN THE IMMUNOCOMPROMISED HOST

      Journal de mycologie medicale
    22. DROMER F; MATHOULIN S; DUPONT B; LAPORTE A; CHARDON H; GREZE H; HAYETTE MP; CHABASSE D; MARTIN M; PULIK M; HAUTEFORT B; LEPENNEC MP; LARFOUILLOUX J; FALLER JP; BARALE T; BOUGESMICHEL C; DELZANIG G; COUPRIE B; BOUGNOUX ME; MASURE O; LEFORT C; DUHAMEL C; BIDAULT C; ZAEGEL M; ALLARD C; LAURENS E; DORMONT J; BEYTOUT J; MOLLO JL; BOUSSOUGANT Y; CORDIER F; BRETAGNE S; GAILLARD JP; PORTIER H; GRISE G; LEBLANC A; BOUCHARD I; NAUCIEL C; LEBEAU B; BOUREE P; LAGARDE A; VINCENT J; DESAILLYCHANSON MA; ELOY O; GRILLOT ML; GOSSET X; CAPBERN P; DARDE ML; LEMERCIER Y; PIENS MA; JANIN G; TREMOLIERES F; QUILICI M; EME A; PIQUET M; REYNES J; GETTLER V; TREVOUX A; KURES L; MORIN O; KERNBAUM S; GARITOUSSAINT M; DELAGE A; BARTHEZ JP; GIUDICELLI Y; JACQUEMIN JL; BOUVRY M; PATEYRON F; TOUBAS D; GUIGEN C; BRASSEUR C; LAFAYE JMP; SIRONDELLE G; GAUTHRON M; JANVIER M; GODINEAU N; DORCHE G; FEGUEUX S; ROUE R; SIMONEAU M; MALHERBE P; KOENIG H; CAHEN P; MUZELLEC Y; LINAS MD; BAIXENCH MT; DECLOSETS F; VERGER J; SALIBA F; PATEY O; DATRY A; LAVARDE V; DERECONDO J; PONSOT G; LAMER C; HENNEQUIN C; TRAORE F; ARBORIO M; DEMATONS C; ROUX P; CHOCHILLON C; DELUOL AM; POIROT JL; DUPOUYCAMET J; BLANC V; BASSET D
      EPIDEMIOLOGY OF CRYPTOCOCCOSIS IN FRANCE - A 9-YEAR SURVEY (1985-1993)

      Clinical infectious diseases
    23. DROMER F; MATHOULIN S; DUPONT B; LETENNEUR L; RONIN O; CHARDON H; HAYETTE MP; BOUCHARA P; HAUTEFORT B; LEPENNEC MP; LARFOUILLOUX J; FALLER M; REBOUX G; COUPRIE B; BOUGNOUX ME; MASURE O; LEFORT C; DUHAMEL C; ZAEGEL M; CAMBON M; BOUSSOUGANT Y; BRETAGNE S; GESLIN M; BERTHELOT M; CAMERLYNCK P; GRISE G; GAUTHIER M; BOUCHARD I; NAUCIEL C; LEBEAU B; ROMAND S; DESAILLYCHANSON MA; ELOY O; GRILLOT ML; BOYER E; GOSSET X; BOUTEILLE B; PIENS MA; JANIN G; TREMOLIERES F; NGUYEN M; EME A; RASPAIL P; KURES L; MORIN O; FELZ M; LEFICHOUX Y; DELAGE A; BARTHEZ JP; NOUAILHAT F; LACROIX C; BLANCHARD A; TOUBAS D; CHEVRIER S; BRASSEUR C; LAFAYE JMP; GODINEAU N; DORCHE G; ROUE R; WALLER J; CAHEN P; MUZELLEC Y; LINAS MD; BAIXENCH MT; VINOCOUR M; VERGER M; RIOU R; ROMAN S; PATEY O; DATRY A; LAVARDE V; DERECONDO J; PONSOT G; LAMER C; HENNEQUIN C; TRAORE F; ARBORIO M; DEMATONS C; ROUX P; CHOCHILLON C; DELUOL AM; BUOT G; POIROT JL; DUPOUYCAMET J; BLANC V; SEGONDS M
      INDIVIDUAL AND ENVIRONMENTAL-FACTORS ASSOCIATED WITH INFECTION DUE TOCRYPTOCOCCUS-NEOFORMANS SEROTYPE-D

      Clinical infectious diseases
    24. DROMER F; MATHOULIN S; DUPONT B; BRUGIERE O; LETENNEUR L
      COMPARISON OF THE EFFICACY OF AMPHOTERICIN-B AND FLUCONAZOLE IN THE TREATMENT OF CRYPTOCOCCOSIS IN HUMAN-IMMUNODEFICIENCY-VIRUS-NEGATIVE PATIENTS - RETROSPECTIVE ANALYSIS OF 83 CASES

      Clinical infectious diseases
    25. DELLION S; IMPROVISI L; DUPONT B; DROMER F
      DIVERSITY AMONG YEASTS ISOLATED FROM PATIENTS WITH AIDS AND ORAL CANDIDOSIS - FOCUS ON FLUCONAZOLE SUSCEPTIBILITY TESTING RESULTS

      Journal de mycologie medicale
    26. GAUTHERET A; DROMER F; BOURHIS JH; ANDREMONT A
      TRICHODERMA PSEUDOKONINGII AS A CAUSE OF FATAL INFECTION IN A BONE-MARROW TRANSPLANT RECIPIENT

      Clinical infectious diseases
    27. DROMER F; MOULIGNIER A; DUPONT B; GUEHO E; BAUDRIMONT M; IMPROVISI L; PROVOST F; GONZALEZCANALI G
      MYELORADICULITIS DUE TO CRYPTOCOCCUS-CURVATUS IN AIDS

      AIDS
    28. BARTDELABESSE E; VANDEVENTER H; GOESSENS W; POIROT JL; LIORET N; VANBELKUM A; DROMER F
      CONTRIBUTION OF MOLECULAR TYPING METHODS AND ANTIFUNGAL SUSCEPTIBILITY TESTING TO THE STUDY OF A CANDIDEMIA CLUSTER IN A BURN CARE UNIT

      Journal of clinical microbiology
    29. GARCIAHERMOSO D; DROMER F; IMPROVISI L; PROVOST F; DUPONT B
      FLUCONAZOLE CONCENTRATIONS IN SALIVA FROM AIDS PATIENTS WITH OROPHARYNGEAL CANDIDOSIS REFRACTORY TO TREATMENT WITH FLUCONAZOLE

      Antimicrobial agents and chemotherapy
    30. DROMER F; RONIN O; DUPONT B
      EPIDEMIOLOGIC DATA ON CRYPTOCOCCOSIS IN F RANCE

      Medecine et maladies infectieuses
    31. DROMER F; VARMA A; RONIN O; MATHOULIN S; DUPONT B
      MOLECULAR TYPING OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-D CLINICAL ISOLATES

      Journal of clinical microbiology
    32. CASADEVALL A; DESHAW M; FAN MX; DROMER F; KOZEL TR; PIROFSKI LA
      MOLECULAR AND IDIOTYPIC ANALYSIS OF ANTIBODIES TO CRYPTOCOCCUS-NEOFORMANS GLUCURONOXYLOMANNAN

      Infection and immunity


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 12:45:19